LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Verition Fund Management LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...

09:14 AM EDT, 09/16/2025 (MT Newswires) -- GSR III Acquisition ( GSRT ) said Tuesday that Terra Innovatum has signed a memorandum of understanding with Argentina's Conuar to supply critical components for the production of Terra Innovatum's Solo micro-modular nuclear reactor. Under the agreement, Terra Innovatum and Conuar will launch pilot programs to evaluate the scope and pricing for Conuar...

09:15 AM EDT, 09/16/2025 (MT Newswires) -- Lantern Pharma ( LTRN ) said Tuesday a phase 1a trial evaluating its drug LP-184 as a potential treatment for advanced relapsed or refractory solid tumors met all primary endpoints and showed a strong safety profile, favorable pharmacokinetics, and early signs of antitumor activity. The company said no dose-limiting toxicities were reported in...

* Novo seeking to reignite growth after Wegovy overtaken by rival * To test next-generation obesity drugs as broader treatments * Areas could include knee osteoarthritis and sleep apnea * Results of semaglutide Alzheimer's trial expected by year-end (Adds details from interview in paragraphs 5-7, 10) By Stine Jacobsen and Maggie Fick COPENHAGEN, Sept 16 (Reuters) - Novo Nordisk, looking...